(Total Views: 795)
Posted On: 10/12/2022 4:52:09 PM
Post# of 154759
There has never been a public release of NF-kB reduction percentages for leronlimab. Maraviroc has shown a significant reduction but the percent is also not public. That leronlimab reduces NF-kB through downregulation of PI3K/AKT I would think it would do very well.
(9)
(0)
